J&J Hedging Reliance on Drugs With Guidant Acquisition
This article is from the archive of The New York Sun before the launch of its new website in 2022. The Sun has neither altered nor updated such articles but will seek to correct any errors, mis-categorizations or other problems introduced during transfer.
By KEITH SNIDER
||National